vs

Side-by-side financial comparison of MADRIGAL PHARMACEUTICALS, INC. (MDGL) and Sphere Entertainment Co. (SPHR). Click either name above to swap in a different company.

Sphere Entertainment Co. is the larger business by last-quarter revenue ($393.8M vs $321.1M, roughly 1.2× MADRIGAL PHARMACEUTICALS, INC.). Sphere Entertainment Co. runs the higher net margin — 16.4% vs -18.2%, a 34.7% gap on every dollar of revenue.

Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases, such as primary biliary cirrhosis (PBC) now called primary biliary cholangitis, non-alcoholic fatty liver disease, cirrhosis, portal hypertension, primary sclerosing cholangitis and also the intestinal disorder, bile acid diarrhea.

Sphere Entertainment Co. is an American entertainment holding company based in New York City, and controlled by the family of Charles Dolan. It owns the Sphere event venue in Paradise, Nevada, in the Las Vegas Valley and New York-based regional sports network chain MSG Networks.

MDGL vs SPHR — Head-to-Head

Bigger by revenue
SPHR
SPHR
1.2× larger
SPHR
$393.8M
$321.1M
MDGL
Higher net margin
SPHR
SPHR
34.7% more per $
SPHR
16.4%
-18.2%
MDGL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MDGL
MDGL
SPHR
SPHR
Revenue
$321.1M
$393.8M
Net Profit
$-58.6M
$64.7M
Gross Margin
Operating Margin
-18.6%
7.3%
Net Margin
-18.2%
16.4%
Revenue YoY
210.8%
Net Profit YoY
1.4%
EPS (diluted)
$-2.55
$2.42

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MDGL
MDGL
SPHR
SPHR
Q4 25
$321.1M
$393.8M
Q3 25
$287.3M
$262.1M
Q2 25
$212.8M
$282.2M
Q1 25
$137.3M
$280.1M
Q4 24
$103.3M
Q3 24
$62.2M
$227.1M
Q2 24
$272.6M
Q1 24
$0
$320.6M
Net Profit
MDGL
MDGL
SPHR
SPHR
Q4 25
$-58.6M
$64.7M
Q3 25
$-114.2M
$-101.2M
Q2 25
$-42.3M
$151.8M
Q1 25
$-73.2M
$-82.0M
Q4 24
$-59.4M
Q3 24
$-107.0M
$-105.3M
Q2 24
$-46.6M
Q1 24
$-147.5M
$-47.2M
Gross Margin
MDGL
MDGL
SPHR
SPHR
Q4 25
Q3 25
Q2 25
Q1 25
96.7%
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
MDGL
MDGL
SPHR
SPHR
Q4 25
-18.6%
7.3%
Q3 25
-39.7%
-49.5%
Q2 25
-22.2%
-17.8%
Q1 25
-57.8%
-28.1%
Q4 24
-64.8%
Q3 24
-187.1%
-51.8%
Q2 24
-66.3%
Q1 24
-12.6%
Net Margin
MDGL
MDGL
SPHR
SPHR
Q4 25
-18.2%
16.4%
Q3 25
-39.8%
-38.6%
Q2 25
-19.9%
53.8%
Q1 25
-53.4%
-29.3%
Q4 24
-57.5%
Q3 24
-172.0%
-46.4%
Q2 24
-17.1%
Q1 24
-14.7%
EPS (diluted)
MDGL
MDGL
SPHR
SPHR
Q4 25
$-2.55
$2.42
Q3 25
$-5.08
$-2.80
Q2 25
$-1.90
$3.39
Q1 25
$-3.32
$-2.27
Q4 24
$-2.50
Q3 24
$-4.92
$-2.95
Q2 24
$-1.33
Q1 24
$-7.38
$-1.33

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MDGL
MDGL
SPHR
SPHR
Cash + ST InvestmentsLiquidity on hand
$198.7M
Total DebtLower is stronger
$339.9M
$692.7M
Stockholders' EquityBook value
$602.7M
$2.2B
Total Assets
$1.3B
$4.2B
Debt / EquityLower = less leverage
0.56×
0.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MDGL
MDGL
SPHR
SPHR
Q4 25
$198.7M
Q3 25
$295.7M
$384.8M
Q2 25
$186.2M
$355.7M
Q1 25
$183.6M
$465.0M
Q4 24
$100.0M
Q3 24
$232.7M
Q2 24
$559.8M
Q1 24
$622.5M
Total Debt
MDGL
MDGL
SPHR
SPHR
Q4 25
$339.9M
$692.7M
Q3 25
$339.8M
$733.8M
Q2 25
$118.4M
$743.8M
Q1 25
$118.0M
$1.3B
Q4 24
$117.6M
Q3 24
$117.1M
$1.4B
Q2 24
$1.4B
Q1 24
$116.1M
$1.4B
Stockholders' Equity
MDGL
MDGL
SPHR
SPHR
Q4 25
$602.7M
$2.2B
Q3 25
$625.7M
$2.2B
Q2 25
$696.0M
$2.3B
Q1 25
$710.6M
$2.1B
Q4 24
$754.4M
Q3 24
$777.2M
$2.3B
Q2 24
$2.4B
Q1 24
$850.8M
$2.4B
Total Assets
MDGL
MDGL
SPHR
SPHR
Q4 25
$1.3B
$4.2B
Q3 25
$1.4B
$4.1B
Q2 25
$1.0B
$4.2B
Q1 25
$996.6M
$4.4B
Q4 24
$1.0B
Q3 24
$1.1B
$4.6B
Q2 24
Q1 24
$1.1B
$4.9B
Debt / Equity
MDGL
MDGL
SPHR
SPHR
Q4 25
0.56×
0.31×
Q3 25
0.54×
0.34×
Q2 25
0.17×
0.32×
Q1 25
0.17×
0.62×
Q4 24
0.16×
Q3 24
0.15×
0.59×
Q2 24
0.57×
Q1 24
0.14×
0.57×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MDGL
MDGL
SPHR
SPHR
Operating Cash FlowLast quarter
$-133.5M
$180.2M
Free Cash FlowOCF − Capex
$-133.8M
FCF MarginFCF / Revenue
-41.7%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
2.78×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MDGL
MDGL
SPHR
SPHR
Q4 25
$-133.5M
$180.2M
Q3 25
$79.8M
$115.8M
Q2 25
$-47.1M
$-59.1M
Q1 25
$-88.9M
$6.3M
Q4 24
$-104.5M
Q3 24
$-67.0M
$34.1M
Q2 24
$-72.4M
Q1 24
$-149.2M
$101.0M
Free Cash Flow
MDGL
MDGL
SPHR
SPHR
Q4 25
$-133.8M
Q3 25
$79.0M
Q2 25
Q1 25
Q4 24
$-104.7M
Q3 24
$-67.8M
Q2 24
Q1 24
$-149.5M
FCF Margin
MDGL
MDGL
SPHR
SPHR
Q4 25
-41.7%
Q3 25
27.5%
Q2 25
Q1 25
Q4 24
-101.3%
Q3 24
-109.0%
Q2 24
Q1 24
Capex Intensity
MDGL
MDGL
SPHR
SPHR
Q4 25
0.1%
Q3 25
0.3%
Q2 25
0.0%
Q1 25
0.0%
Q4 24
0.2%
Q3 24
1.3%
Q2 24
Q1 24
Cash Conversion
MDGL
MDGL
SPHR
SPHR
Q4 25
2.78×
Q3 25
Q2 25
-0.39×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MDGL
MDGL

Rebates Customer Fees Credits Co Pay Assistance And Other$208.5M65%
Other$76.0M24%
Chargebacks Discounts For Prompt Pay And Other Allowances$36.6M11%

SPHR
SPHR

Ticketing And Venue License Fee Revenues$198.5M50%
Media Networks Revenue$120.1M30%
Sponsorship Signage Exosphere Advertising And Suite Licenses$32.2M8%
Food Beverage And Merchandise Revenues$27.6M7%
Other$13.2M3%
Related Party$2.3M1%

Related Comparisons